LYRA Lyra Therapeutics
- 0.420
- -0.102-19.46%
- 0.410
- -0.010-2.36%
Lyra Therapeutics News
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersNuwellis (NASDAQ:NUWE) shares rose 57.7% to $0.27 during Tuesday's regular session. The company's market cap stands at $4.1 million. As per the news, the Q1 earnings report came out today. Biov
Jefferies Cuts Lyra to Hold in Wake of Failed Phase 3 Study
Where Lyra Therapeutics Stands With Analysts
Analysts' ratings for Lyra Therapeutics (NASDAQ:LYRA) over the last quarter vary from bullish to bearish, as provided by 5 analysts.The table below provides a snapshot of their recent ratings, showcas
Lyra Therapeutics Price Target Announced at $2.00/Share by HC Wainwright & Co.
Lyra Therapeutics Price Target Announced at $2.00/Share by HC Wainwright & Co.
Express News | Lyra Therapeutics Shares Are Trading Lower on Continued Weakness After the Company on Monday Announced the ENLIGHTEN 1 Trial Did Not Meet Its Primary Endpoint. Also, Jefferies Downgraded the Stock From Buy to Hold and Lowered Its Price Target From $10...
Lyra Therapeutics Cut to Hold From Buy by Jefferies
Lyra Therapeutics Cut to Hold From Buy by Jefferies
Jefferies Downgrades Lyra Therapeutics to Hold, Price Target at $0.50
Jefferies Downgrades Lyra Therapeutics to Hold, Price Target at $0.50.
HC Wainwright Downgrades Lyra Therapeutics to Neutral From Buy
HC Wainwright Downgrades Lyra Therapeutics to Neutral From Buy.
Analysts Offer Insights on Healthcare Companies: Lyra Therapeutics (LYRA), Bristol-Myers Squibb (BMY) and Axsome Therapeutics (AXSM)
Sell Rating on Lyra Therapeutics Amid Phase 3 Study Failure and Funding Concerns
Express News | Lyra Therapeutics Inc : Jefferies Cuts to Hold From Buy; Cuts Target Price to $0.5 From $10
Global Equities Roundup: Market Talk
The latest Market Talks covering Equities. Published exclusively on Dow Jones Newswires throughout the day. 1435 ET - AutoCanada felt the weight of a softer consumer environment, which translated int
Trending Stocks Today: Nuvo Group Shoots up 199.5%
May 6th - US stocks trending in regular trading hours.Gainers: $Nuvo Group(NUVO.US)$ surges 199.5% to $6.11 with a turnover of $245.38 million. $Strong Global Entertainment(SGE.US)$ shoots up 115.77%
Crude Oil Gains 1%; TreeHouse Foods Shares Fall After Q1 Results
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Monday.The Dow traded up 0.18% to 38,744.60 while the NASDAQ rose 0.69% to 16,267.82. The S&
12 Health Care Stocks Moving In Monday's Intraday Session
GainersNRX Pharmaceuticals (NASDAQ:NRXP) shares increased by 39.5% to $2.93 during Monday's regular session. The company's market cap stands at $30.9 million. TC BioPharm (Holdings) (NASDAQ:TCBP) stoc
Study Failure Has Lyra Trading for Less Than Cash -- Market Talk
1144 ET - The failure of Lyra Therapeutics' LYR-210 in a Phase 3 study is "clearly disappointing," say analysts at William Blair, who downgrade the shares to market perform from outperform and say the
Express News | Lyra Therapeutics Inc : Btig Cuts to Neutral From Buy
Nasdaq Jumps 100 Points; Tyson Foods Sales Miss Views
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 100 points on Monday.The Dow traded up 0.25% to 38,772.28 while the NASDAQ rose 0.64% to 16,260.19. The S&P 500 also
BTIG Downgrades Lyra Therapeutics (LYRA) to a Hold
Lyra Therapeutics Shares Plummet 90% After Chronic Rhinosinusitis Drug Fails in Study
By Colin Kellaher Lyra Therapeutics shares collapsed to an all-time low on Monday after the clinical-stage biotechnology company reported the failure of its lead drug candidate in a late-stage trial
Analysis
Price Target
No Data
